These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 18003666

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Homocysteine lowering and cardiovascular events after acute myocardial infarction.
    Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K, NORVIT Trial Investigators.
    N Engl J Med; 2006 Apr 13; 354(15):1578-88. PubMed ID: 16531614
    [Abstract] [Full Text] [Related]

  • 3. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, Gaziano JM, Veterans Affairs Site Investigators.
    JAMA; 2007 Sep 12; 298(10):1163-70. PubMed ID: 17848650
    [Abstract] [Full Text] [Related]

  • 4. Homocysteine lowering with folic acid and B vitamins in vascular disease.
    Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J, Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators.
    N Engl J Med; 2006 Apr 13; 354(15):1567-77. PubMed ID: 16531613
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure.
    Bernasconi AR, Liste A, Del Pino N, Rosa Diez GJ, Heguilén RM.
    Nephrology (Carlton); 2006 Apr 13; 11(2):137-41. PubMed ID: 16669976
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial.
    Vermeulen EG, Stehouwer CD, Valk J, van der Knaap M, van den Berg M, Twisk JW, Prevoo W, Rauwerda JA.
    Eur J Clin Invest; 2004 Apr 13; 34(4):256-61. PubMed ID: 15086356
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
    de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD.
    Int J Geriatr Psychiatry; 2012 Jun 13; 27(6):592-600. PubMed ID: 21780182
    [Abstract] [Full Text] [Related]

  • 16. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
    Vianna AC, Mocelin AJ, Matsuo T, Morais-Filho D, Largura A, Delfino VA, Soares AE, Matni AM.
    Hemodial Int; 2007 Apr 13; 11(2):210-6. PubMed ID: 17403173
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.